Tag:
Vantia Therapeutics
Latest Headlines
Latest Headlines
Upstart biotech banks $13M for new eye drugs
Backed by a pair of prestigious Harvard investigators and some preclinical ophthalmology assets picked up from Vantia Therapeutics, the U.K.'s KalVista Pharmaceuticals has banked £8
Vantia touts its midstage therapy for menstrual cramps
The UK's Vantia has been touting the potential of a new therapy designed to ease severe menstrual cramps. And the developer has garnered headlines around the world for a new study of theirs on the
